Condition

B Cell Chronic Lymphocytic Leukemia (3)

Mantle-cell Lymphoma (1)

Overall Status

Completed (2)

Recruiting (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

French Innovative Leukemia Organisation (1)

Genzyme, a Sanofi Company (1)

University of Milano Bicocca (1)

Collaborator

Intervention

alemtuzumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (1)

Observational (1)

Observational [Patient Registry] (1)

b cell chronic lymphocytic leukemia

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

"Don't Eat me" Signal in Hematological Malignancies: CD24 as New

Recruiting

Mantle-cell Lymphoma
B Cell Chronic Lymphocytic Leukemia

Monza, MB, Italy

Andrea Aroldi

May 24, 2023

B Cell Chronic Lymphocytic Leukemia Trial in Tours

Completed

B Cell Chronic Lymphocytic Leukemia

Tours, France
+1 more

May 15, 2020

B Cell Chronic Lymphocytic Leukemia Trial in United States (alemtuzumab)

Completed

B Cell Chronic Lymphocytic Leukemia

alemtuzumab

Tucson, Arizona
+19 more

Jul 27, 2016